ATE66613T1 - Immunstimulierende mittel. - Google Patents
Immunstimulierende mittel.Info
- Publication number
- ATE66613T1 ATE66613T1 AT86309526T AT86309526T ATE66613T1 AT E66613 T1 ATE66613 T1 AT E66613T1 AT 86309526 T AT86309526 T AT 86309526T AT 86309526 T AT86309526 T AT 86309526T AT E66613 T1 ATE66613 T1 AT E66613T1
- Authority
- AT
- Austria
- Prior art keywords
- immune stimulants
- muramyldipeptide
- exhibits
- stimulants
- immune
- Prior art date
Links
- 229960001438 immunostimulant agent Drugs 0.000 title 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29147185 | 1985-12-24 | ||
| EP19860309526 EP0228833B1 (de) | 1985-12-24 | 1986-12-08 | Immunstimulierende Mittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE66613T1 true ATE66613T1 (de) | 1991-09-15 |
Family
ID=17769299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86309526T ATE66613T1 (de) | 1985-12-24 | 1986-12-08 | Immunstimulierende mittel. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4780313A (de) |
| EP (1) | EP0228833B1 (de) |
| JP (1) | JPS62228026A (de) |
| AT (1) | ATE66613T1 (de) |
| AU (1) | AU601957B2 (de) |
| CA (1) | CA1285479C (de) |
| DE (1) | DE3681145D1 (de) |
| DK (1) | DK585886A (de) |
| IL (1) | IL80927A0 (de) |
| PH (1) | PH25112A (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5503841A (en) * | 1985-09-20 | 1996-04-02 | Cetus Oncology Corporation | Human IL-2 as a vaccine adjuvant |
| US5643565A (en) * | 1985-09-20 | 1997-07-01 | Chiron Corporation | Human IL-2 as a vaccine adjuvant |
| IL83350A0 (en) * | 1986-08-13 | 1987-12-31 | Takeda Chemical Industries Ltd | Pharmaceutical compositions comprising interleukin and intterferon active substances |
| AU603820B2 (en) * | 1986-08-13 | 1990-11-29 | Takeda Chemical Industries Ltd. | Antitumor agent |
| US4938956A (en) * | 1987-04-01 | 1990-07-03 | International Minerals & Chemical Corp. | Synergistic immunostimulating composition and method |
| AU609524B2 (en) * | 1987-09-02 | 1991-05-02 | Daiichi Pharmaceutical Co., Ltd. | Method for preventing or treating thrombocytopenia |
| US4895835A (en) * | 1987-11-20 | 1990-01-23 | Nisshin Oil Mills, Ltd. | Muramyl peptide derivatives and use thereof |
| US4950647A (en) * | 1988-10-04 | 1990-08-21 | Nucleic Acid Research Institute | T cell immunopotentiator |
| DE3902021A1 (de) * | 1989-01-20 | 1990-07-26 | Entec | Verwendung von antipeptidergen mitteln, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen prostatakarzinoms |
| JPH0832638B2 (ja) * | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| DK0494224T3 (da) * | 1989-09-25 | 2000-08-07 | Univ Utah Res Found | Anvendelse af steroidhormoner i sammensætninger til induktion af T-cellelymfokinproduktion |
| US5250296A (en) * | 1990-11-29 | 1993-10-05 | Takeda Chemical Industries, Ltd. | Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine |
| FR2684878B1 (fr) * | 1991-12-12 | 1994-02-11 | Roussel Uclaf | Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation. |
| US5258407A (en) * | 1991-12-31 | 1993-11-02 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
| US5449691A (en) * | 1991-12-31 | 1995-09-12 | Sterling Winthrop Inc. | 3,4-disubstituted anilines-immunomodulating agents |
| FR2702659B1 (fr) * | 1993-03-19 | 1995-08-25 | Vacsyn Sa | Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine. |
| EP0689449B1 (de) * | 1993-03-19 | 2002-10-30 | Vacsyn S.A. | Zusammensetzungen für die anwendung in menschlicher therapie, charakterisiert durch die assoziation eines muramylpeptids mit einem cytokin |
| CA2163652A1 (en) * | 1993-05-27 | 1994-12-08 | Carol A. Nacy | Compositions and methods for treating cancer and hyperproliferative disorders |
| US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| US6008319A (en) | 1996-12-23 | 1999-12-28 | University Of Southern California | Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| US20030166147A1 (en) * | 2001-12-14 | 2003-09-04 | Lee Chichang | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| US20040152170A1 (en) * | 2001-12-14 | 2004-08-05 | Lee Chichang | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| EP1490481A4 (de) * | 2001-12-14 | 2005-12-07 | Centocor Inc | Zur herstellung von proteinen in chemisch definierten medien geeignete klonale myelomzellinien |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1563561A (en) * | 1976-06-23 | 1980-03-26 | Daiichi Seiyaku Co | Muramyldipeptide derivatives and process for the preparation thereof |
| FR2446292A1 (fr) * | 1979-01-12 | 1980-08-08 | Anvar | Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant |
| JPS55111499A (en) * | 1979-02-21 | 1980-08-28 | Takeda Chem Ind Ltd | Glucosamine derivative and its preparation |
| FR2522967B1 (fr) * | 1982-03-15 | 1986-03-07 | Anvar | Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant |
| JPH0751511B2 (ja) * | 1982-03-15 | 1995-06-05 | 味の素株式会社 | インターロイキン2を含有してなる癌治療剤 |
| US4518584A (en) * | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| JPS60115528A (ja) * | 1983-11-28 | 1985-06-22 | Takeda Chem Ind Ltd | ヒトインタ―ロイキン―2蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物 |
| IL76360A0 (en) * | 1984-09-26 | 1986-01-31 | Takeda Chemical Industries Ltd | Mutual separation of proteins |
-
1986
- 1986-12-05 DK DK585886A patent/DK585886A/da not_active Application Discontinuation
- 1986-12-08 EP EP19860309526 patent/EP0228833B1/de not_active Expired - Lifetime
- 1986-12-08 AT AT86309526T patent/ATE66613T1/de active
- 1986-12-08 DE DE8686309526T patent/DE3681145D1/de not_active Expired - Fee Related
- 1986-12-08 AU AU66189/86A patent/AU601957B2/en not_active Ceased
- 1986-12-10 IL IL80927A patent/IL80927A0/xx unknown
- 1986-12-15 CA CA000525278A patent/CA1285479C/en not_active Expired - Lifetime
- 1986-12-18 US US06/943,924 patent/US4780313A/en not_active Expired - Fee Related
- 1986-12-22 JP JP61307382A patent/JPS62228026A/ja active Pending
- 1986-12-22 PH PH34636A patent/PH25112A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL80927A0 (en) | 1987-03-31 |
| AU601957B2 (en) | 1990-09-27 |
| CA1285479C (en) | 1991-07-02 |
| EP0228833A2 (de) | 1987-07-15 |
| DK585886A (da) | 1987-06-25 |
| DK585886D0 (da) | 1986-12-05 |
| PH25112A (en) | 1991-02-19 |
| AU6618986A (en) | 1987-06-25 |
| JPS62228026A (ja) | 1987-10-06 |
| DE3681145D1 (de) | 1991-10-02 |
| US4780313A (en) | 1988-10-25 |
| EP0228833B1 (de) | 1991-08-28 |
| EP0228833A3 (en) | 1988-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE66613T1 (de) | Immunstimulierende mittel. | |
| GR890100838A (el) | Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της. | |
| DE3880593D1 (de) | Arzneizubereitungen mit retardierter wirkstofffreisetzung. | |
| DE3650082D1 (de) | Orale impfstoffe. | |
| DE3671372D1 (de) | Etoposid-praeparate. | |
| DE68903192D1 (de) | Orale praeparate. | |
| ES554125A0 (es) | Procedimiento de preparar hidroxamatos farmaceuticamente activos. | |
| DK224687D0 (da) | Aktive forbindelser | |
| NL970029I1 (nl) | Benzimidazoolderivaten, bereiding en therapeutische toepassing. | |
| NO861517L (no) | Stabilt smakstoffholdig tannpleiemiddel. | |
| FI88825C (fi) | Aktivt pansar | |
| DE3682960D1 (de) | Pharmazeutische praeparate. | |
| NO870533D0 (no) | Terapeutisk aktive 3-alkoksy-2-aminopropylaminer. | |
| NO874193D0 (no) | Farmasoeytiske preparater. | |
| FI861193L (fi) | Stabilt gammainterferonpreparat. | |
| FI862444L (fi) | Medicinhoelje. | |
| DE3675679D1 (de) | Menschliche bauchspeichelelastase. | |
| FI861253L (fi) | Revolverkolvstruktur. | |
| EP0257890A3 (de) | Antikrebsmittel | |
| IT8520591A0 (it) | Formulazione farmaceutica. | |
| DK674187A (da) | Aktive forbindelser | |
| FI864235A7 (fi) | Interleukiini-2-johdos, sen valmistus ja käyttö. | |
| NO864764D0 (no) | Vaksine. | |
| FI860761L (fi) | Hopfaellbar stol. | |
| IT8522712A0 (it) | Preparazioni farmacetuche per uso anticataratta. |